If this hypothesis is demonstrated, the control of the ratio Ang-Tie2 can become a sepsis-specific treatment via restoring the eGC and the microvascular barrier, thus accelerating mechanisms mediating angiogenic repair. The gene discussed is TEK; the disease is Sepsis.